EMA Recommends Lilly's Foundayo for Weight Management
Eli Lilly’s Foundayo has received an EMA recommendation for marketing authorisation as an oral GLP-1 medicine for weight management and Type 2 Diabetes.
Oral GLP-1 Receptor Agonist | 19/10/2026 | By News Bureau | 143
Merck Signs Exclusive Global License Deal with Hansoh Pharma for Oral GLP-1 Receptor Agonist
Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535.
Oral GLP-1 Receptor Agonist | 19/12/2024 | By Aishwarya | 631
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy